Physician profile
Sierra Cavan
NPI 1548940349
$378.32
in general payments reported to CMS, 2019-2025
10 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $61.04 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $378.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $95.80 | 2024-2025 | Verquvo |
| Recor Medical INC | $69.55 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Amgen INC. | $44.25 | 2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $40.44 | 2025 | Camzyos |
| Scpharmaceuticals INC. | $24.20 | 2025 | |
| Boston Scientific Corporation | $23.96 | 2025 | Watchman Access System |
| Kestra Medical Technology Services, INC. | $22.33 | 2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $20.53 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.15 | 2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $18.11 | 2024 | Wainua |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sierra Cavan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.